KNOXVILLE, Tenn. (AP) — Chaz Lanier scored 18 and No. 7 Tennessee extended its season-opening winning streak to seven games with a 78-35 victory over UT Martin on Wednesday. Felix Okpara had 10 points and 11 rebounds for the Volunteers (7-0). Zakai Zeigler added 11 points and nine assists, and Igor Milicic had 13 rebounds and nine points. The Skyhawks (2-5) were led by Josu Grullon's 15 points. Lanier scored 11 points in the first half as Tennessee built a 35-20 lead at the half. Grullon had 10 for UT Martin. UT Martin: Dropped its fifth straight after two opening wins under first-year coach Jeremy Shulman. After 21 wins last year, the Skyhawks brought in 16 newcomers this season. They are picked to finish 10th in the Ohio Valley Conference. Tennessee: After receiving the news that 6-foot-9 sophomore J.P. Estrella will miss the entire season with a foot injury, the Vols have had to go back to the drawing board to determine their rotation on the front court. Estrella had been coming off the bench with Cade Phillips to spell Igor Milicic and Felix Okpara. What that big man rotation looks like will be interesting. From late in the first half to early in the second half, Tennessee scored 14 straight points and turned a 10-point lead into a 44-20 advantage. Zakai Zeigler had five of those points. UT Martin committed 18 turnovers. Five of those were shot-clock violations. Tennessee scored 24 points off the turnovers. UT Martin will be at Charleston Southern next Tuesday. Tennessee will host Syracuse next Tuesday in the SEC/ACC Challenge. Get poll alerts and updates on the AP Top 25 throughout the season. Sign up here . AP college basketball: https://apnews.com/hub/ap-top-25-college-basketball-poll and https://apnews.com/hub/college-basketball(NAPSI)—The holidays are the most wonderful time of the year, but when the average American is spending nearly $1,000 on gifts, food, and decorations, they can also be the most stressful. For many, the pressure to create a picture-perfect holiday can stretch budgets a bit too far. Many of today’s shoppers seek advice from their favorite online influencers, sourcing creative hacks, recipes, DIY projects, and tips to keep the holidays magical without overspending. In fact, 69% of consumers say they value and actively seek out influencer recommendations. Now, questions don’t need to get buried in the comments. This December, TextNow is flipping the script on holiday stress by introducing the Holiday Hotline , a free resource to help you navigate the season, with advice a mere text away. Whether it’s finding affordable gifts, creating a festive dinner on a budget, or even learning how to save on your monthly bills, the Holiday Hotline can make things simpler, cheaper, and—perhaps most importantly—more joyful. TextNow Holiday Hotline: Expert Advice at Your Fingertips From December 5–10, TextNow’s Holiday Hotline connects you with relatable experts (aka some of your favorite influencers including social media creator and podcast host Remi Cruz, Kayla Savings, and Melissa Weiss) who will share their go-to tips for a budget-friendly holiday. Here’s what you can expect: • Holiday Budgeting 101: Learn simple ways to stretch every dollar and avoid those dreaded post-holiday bills. • Affordable Gift-Giving Ideas: Thoughtful, creative gifts that won’t break the bank. • Festive Decorating on a Dime: Transform your home into a holiday wonderland with budget-friendly hacks. • Stress-Free Holiday Cooking: Recipes and meal-planning tips to impress your guests. Need more advice? Just text the hotline at 310-299-3584, and you’ll get personalized, practical tips sent straight to your phone. Win $1,000 for Your Holiday Dinner As if free expert advice wasn’t enough, TextNow is also giving you the chance to win big this holiday season. Enter the $1,000 Dinner Giveaway for a shot at a $1,000 gift card to cover your holiday expenses—whether it’s for food, gifts, travel, or whatever else makes your season special. Entering is simple: 1.Head to TextNow’s Instagram . 2.Like the giveaway post. 3.Share your best holiday tip in the comments (bonus: share the post to your story for an extra entry). 4.The giveaway runs from December 5-12, with winners announced from December 13-16. Save More This Holiday Season TextNow is more than just a phone service—it’s a way to take control of your budget, not just during the holidays but year-round. • Free Phone Service: Unlimited calling and texting on the nation’s largest 5G network free. No gimmicks, no contracts. • Free Essential Data: Get free data for such essential apps as maps, rideshare, and email when you activate your SIM card. • Additional Flexible Data Plans: Add extra data only when you need it, with hourly, daily, or monthly passes. Getting started with TextNow is easy. Download the app to call and text for free over Wi-Fi or unlock free cellular service with a $4.99 SIM card. Learn More For more details, visit www.TextNow.com . Word Count: 491 Best trending stories from the week. Success! An email has been sent to with a link to confirm list signup. Error! There was an error processing your request. You may occasionally receive promotions exclusive discounted subscription offers from the Roswell Daily Record. Feel free to cancel any time via the unsubscribe link in the newsletter you received. You can also control your newsletter options via your user dashboard by signing in.
Fundamental Global Inc. Declares Cash Dividend on Its 8.00% Cumulative Preferred Stock, Series AMINNEAPOLIS, Nov. 27, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), a global provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data (“iRWDTM”), inclusive of electronic health records, laboratory results and, uniquely, medical imaging, today announced the Company received an expected notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, due to the Company’s failure to timely file its Form 10-Q for the fiscal quarter ended September 30, 2024 (the “New Delinquent Filing”) with the Securities and Exchange Commission (the “SEC”), the Company is not in compliance with Nasdaq’s continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires the timely filing of all required periodic reports with the SEC. Previously, Nasdaq granted the Company an exception until December 11, 2024 to file its delinquent Quarterly Reports on Form 10-Q for the quarterly periods ended March 31, 2024 and June 30, 2024 (collectively with the New Delinquent Filing, the “Delinquent Filings”). As a result, any additional Nasdaq exception to allow the Company to regain compliance with all delinquent filings, including the New Delinquent Filing, will be required to be filed by December 11, 2024. In accordance with Nasdaq’s listing rules, the Company has until December 6, 2024 to submit to Nasdaq an update to the Company’s original plan to regain compliance with the Rule. The Company is working diligently to complete the Delinquent Filings. The Company intends to file the Delinquent Filings as soon as practicable to regain compliance with the Nasdaq Listing Rules. No assurance can be given that the Company will be able to regain compliance with the aforementioned listing requirement or maintain compliance with the other continued listing requirements set forth in the Nasdaq Listing Rules. The Notice has no immediate effect on the listing of the Company’s common stock or warrants on The Nasdaq Capital Market. About OneMedNet Corporation OneMedNet provides innovative solutions that unlock the significant value contained within the Real-World Data (“RWD”) repositories of over 1,400 healthcare system and provider sites that currently comprise its iRWDTM network. OneMedNet’s proprietary iRWDTM platform provides secure, comprehensive management of diverse clinical data types, including electronic health records, ECGs, EEGs, prescriptions, physician notes, laboratory results, and uniquely, medical imaging. Employing its robust iRWDTM platform, the Company securely de-identifies, searches, and curates the clinical data, bringing a wealth of internal and third-party research opportunities to its drug, medical device and imaging/diagnostic AI development customers. OneMedNet’s platform is designed to address diverse clinical requirements across various domains, such as rare diseases, central nervous system disorders, oncology, cardiology and women’s health. The Company is committed to delivering precise and robust research support services that span the entire continuum of care. This commitment is a cornerstone of OneMedNet’s strategy to enhance patient outcomes and help pave the next wave of healthcare innovation. For more information, please visit www.onemednet.com . Cautionary Note Regarding Forward-Looking Statements This press release contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of OneMedNet; our ability to keep pace with new technology and changing market needs; the competitive environment of our business; the timeline for the Company to regain compliance with the listing rules of The Nasdaq Stock Market LLC relating to the timely filing of periodic reports with the SEC; risks inherent with investing in Bitcoin, including Bitcoin’s volatility; and our ability to implement our Bitcoin treasury strategy and its effects on our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this press release and other statements made from time to time by us or our representatives might not occur. OneMedNet Contacts: Michael Wong, Director of Marketing Phone: 800.918.7189 Email: michael.wong@onemednet.com SOURCE: ONEMEDNET CORPORATIONGold miner Metals Exploration closes in on £90m deal to buy rival Condor By EMILY HAWKINS Updated: 22:00 GMT, 2 December 2024 e-mail View comments A gold miner backed by Nick Candy is closing in on a deal to buy a rival for up to £90million. AIM-listed Metals Exploration has made an offer worth £67.5million up front, and a potential £22.6million more in future, to buy Condor Gold. The announcement came after the Mail yesterday revealed Metals – which is 38 per cent owned by property magnate Candy – was prepared to go hostile in the bid. But Jim Mellon, Condor’s non-executive chairman and one of Britain’s richest men, has given an irrevocable commitment to back the deal. This means he would vote against any rival bid. The deal will bring together two of Britain’s most colourful businessmen. Mellon, 67, who has been described as Britain’s Warren Buffett, owns 26 per cent of Condor, which is listed on AIM as well as the Toronto stock exchange. Glittering: Property magnate Nick Candy (pictured with wife Holly Valance) has a 38% stake in AIM-listed Metals Exploration Candy, 51, is married to pop star and actor Holly Valance and made his fortune through luxury London developments. Shares in Condor soared 19.79 per cent, or 4.75p, to 28.75p yesterday, but are still down by almost two thirds over the past decade. Metals shares, meanwhile, tumbled 8.8 per cent, or 0.5p, to 5.2p. ‘Metals obviously think they can get a bargain,’ said Dan Coatsworth, investment analyst at broker AJ Bell. RELATED ARTICLES Previous 1 Next Neglect imperils Royal Mail: Government should have learned... Political turmoil in France sends euro tumbling and... Share this article Share HOW THIS IS MONEY CAN HELP How to choose the best (and cheapest) stocks and shares Isa and the right DIY investing account The deal will see Metals make the extra payment if the amount of gold found at Condor’s mines exceeds estimates. Metals operates in the Philippines and its shares have more than doubled in the past year. Condor Gold is smaller and is the owner of the 2.3m-ounce La India Project in Nicaragua. It first started looking for a buyer for this asset in 2022. DIY INVESTING PLATFORMS AJ Bell AJ Bell Easy investing and ready-made portfolios Learn More Learn More Hargreaves Lansdown Hargreaves Lansdown Free fund dealing and investment ideas Learn More Learn More interactive investor interactive investor Flat-fee investing from £4.99 per month Learn More Learn More Saxo Saxo Get £200 back in trading fees Learn More Learn More Trading 212 Trading 212 Free dealing and no account fee Learn More Learn More Affiliate links: If you take out a product This is Money may earn a commission. These deals are chosen by our editorial team, as we think they are worth highlighting. This does not affect our editorial independence. Compare the best investing account for you Share or comment on this article: Gold miner Metals Exploration closes in on £90m deal to buy rival Condor e-mail Add comment Some links in this article may be affiliate links. If you click on them we may earn a small commission. That helps us fund This Is Money, and keep it free to use. We do not write articles to promote products. We do not allow any commercial relationship to affect our editorial independence. More top storiesNew limb-lengthening breakthrough for young children in Finland
N. Dakota St. 73, West Georgia 61WALTHAM, Mass.--(BUSINESS WIRE)--Dec 6, 2024-- Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced the pending departure of William Kelly, its Chief Financial Officer (CFO), to pursue other career opportunities, after nearly four years of dedicated service with the Company. Mr. Kelly has served as Vicarious Surgical’s CFO since January 2021. He will assist the Company to ensure minimal disruption and a successful transition of responsibilities prior to his departure, which is slated for January 2, 2025. “On behalf of the Company and Board, I want to extend my sincerest gratitude to Bill for his significant contribution over the last few years,” said Adam Sachs, Co-Founder and Chief Executive Officer. “Bill has been an incredible asset to Vicarious Surgical, and we wish him all the best in his future endeavors.” Mr. Kelly added “My tenure at Vicarious Surgical has been a period of significant progress and accomplishment, both for the Company and for me personally. I am deeply grateful for the opportunities I have been afforded and the collaborative spirit of the entire team. I depart with immense pride in our collective achievements and unwavering confidence in the Company's continued success under its strong leadership.” The Company has initiated a CFO succession process and will provide updates as appropriate. About Vicarious Surgical Founded in 2014, Vicarious Surgical is a next generation robotics company, developing a unique disruptive technology with the multiple goals of substantially increasing the efficiency of surgical procedures, improving patient outcomes, and reducing healthcare costs. The Company’s novel surgical approach uses proprietary human-like surgical robots to virtually transport surgeons inside the patient to perform minimally invasive surgery. The Company is led by an experienced team of technologists, medical device professionals and physicians, and is backed by technology luminaries including Bill Gates, Vinod Khosla’s Khosla Ventures, Innovation Endeavors, Jerry Yang’s AME Cloud Ventures, Sun Hung Kai & Co. Ltd and Philip Liang’s E15 VC. The Company is headquartered in Waltham, Massachusetts. Learn more at www.vicarioussurgical.com . Forward-Looking Statements This press release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. The company’s actual results may differ from its expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. All statements other than statements of historical facts contained herein, are forward-looking statements that reflect the current beliefs and expectations of management. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from those discussed in the forward-looking statements. Most of these factors are outside Vicarious Surgical’s control and are difficult to predict. Factors that may cause such differences include, but are not limited to: the ability to maintain the listing of Vicarious Surgical’s Class A common stock on the New York Stock Exchange; the approval, commercialization and adoption of Vicarious Surgical’s initial product candidates and the success of its single-port surgical robot, called the Vicarious Surgical System, and any of its future product candidates and service offerings; changes in applicable laws or regulations; the ability of Vicarious Surgical to raise financing in the future; the success, cost and timing of Vicarious Surgical’s product and service development activities; the potential attributes and benefits of Vicarious Surgical’s product candidates and services; Vicarious Surgical’s ability to obtain and maintain regulatory approval for the Vicarious Surgical System, and any related restrictions and limitations of any approved product; the size and duration of human clinical trials for the Vicarious Surgical System; Vicarious Surgical’s ability to identify, in-license or acquire additional technology; Vicarious Surgical’s ability to maintain its existing license, manufacture, supply and distribution agreements; Vicarious Surgical’s ability to compete with other companies currently marketing or engaged in the development of products and services that Vicarious Surgical is currently marketing or developing; the size and growth potential of the markets for Vicarious Surgical’s product candidates and services, and its ability to serve those markets, either alone or in partnership with others; the pricing of Vicarious Surgical’s product candidates and services and reimbursement for medical procedures conducted using its product candidates and services; the company’s estimates regarding expenses, revenue, capital requirements and needs for additional financing; Vicarious Surgical’s financial performance; economic downturns, political and market conditions and their potential to adversely affect Vicarious Surgical’s business, financial condition and results of operations; Vicarious Surgical’s intellectual property rights and its ability to protect or enforce those rights, and the impact on its business, results and financial condition if it is unsuccessful in doing so; and other risks and uncertainties indicated from time to time in Vicarious Surgical’s filings with the SEC. Vicarious Surgical cautions that the foregoing list of factors is not exclusive. The company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Vicarious Surgical does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based. View source version on businesswire.com : https://www.businesswire.com/news/home/20241206242926/en/ CONTACT: Investors Kaitlyn Brosco Vicarious Surgical Kbrosco@vicarioussurgical.com Media Inquiries media@vicarioussurgical.com KEYWORD: MASSACHUSETTS UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: MEDICAL SUPPLIES TECHNOLOGY OTHER HEALTH HEALTH ROBOTICS HEALTH TECHNOLOGY OTHER TECHNOLOGY MEDICAL DEVICES HOSPITALS SURGERY HARDWARE SOURCE: Vicarious Surgical Inc. Copyright Business Wire 2024. PUB: 12/06/2024 04:05 PM/DISC: 12/06/2024 04:05 PM http://www.businesswire.com/news/home/20241206242926/en
You will bear all civil or criminal legal responsibilities directly or indirectly caused by your actions and speech.
Message board administrators have the right to retain or delete any content in the messages under their jurisdiction.
This site reminds: Do not make personal attacks. Thank you for your cooperation.
mcw casino apps login All rights reserved. Unauthorized reproduction, copying or mirroring is prohibited. Violators will be held accountable.
Statement: All information presented on this site is edited and published by the mcw casino apps login work team. Copyright is reserved. Plagiarism is strictly prohibited. Do not reproduce or mirror without authorization. Otherwise, this site reserves the right to pursue legal liability.
Copyright © 2018 Tencent. All Rights Reserved